“VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA”. 2016. Prospects in Pharmaceutical Sciences 14 (8): 52-56. https://doi.org/10.56782/pps.117.